Abbott Laboratories recalls blood glucose meters

Abbott Laboratories is recalling its FreeStyle InsuLinx Blood Glucose Meters after finding that they display and store incorrect test results for dangerously high blood sugar levels.

The Abbott Park, Ill., company says the meters will display and store readings for of 1,024 milligrams per deciliter or higher at much lower levels. That's an extremely high and rare level that requires immediate medical attention.

The inaccurate readings can lead to a delay in identifying the problem or incorrect treatment. Abbott says that can lead to serious injury or death.

Abbott says customers with the meter should contact its diabetes care customer service or download a software update that resolves the issue.

Johnson & Johnson announced a similar recall last month for several types of its blood glucose meters.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Abbott recalls millions of diabetes testing strips

Dec 22, 2010

(AP) -- The Food and Drug Administration says Abbott Laboratories is recalling up to 359 million testing strips used by diabetics because they can give falsely low blood sugar readings.

Recommended for you

Drug research and development more efficient than expected

Feb 27, 2015

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.